2025
Oral health and rehabilitation in face transplant recipients – a systematic review
Knoedler L, Kauke-Navarro M, Knoedler S, Niederegger T, Hofmann E, Heiland M, Koerdt S, Nahles S, Baecher H. Oral health and rehabilitation in face transplant recipients – a systematic review. Clinical Oral Investigations 2025, 29: 47. PMID: 39760761, PMCID: PMC11703954, DOI: 10.1007/s00784-024-06078-3.Peer-Reviewed Original ResearchConceptsNewcastle-Ottawa ScaleLevel of evidenceOral healthFT patientsLong-term transplant successNewcastle-Ottawa Scale scoreOral health protocolOral health assessmentSevere facial defectsFT recipientsOral mucosa biopsiesImproving clinical outcomesSystematic reviewFace transplant recipientsFailed osseointegrationEndodontic treatmentDental treatmentFT caseTooth extractionTransplant recipientsDental implantsOverall patient healthOral mucosaStandard care protocolCase series
2017
Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)
Kruse-Jarres R, Callaghan M, Croteau S, Jimenez-Yuste V, Khoo L, Liesner R, Matsushita T, Recht M, Young G, Chang T, Dhalluin C, Mu Y, Xu J, Devenport J, Ko R, Solari P, Oldenburg J. Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2). Blood 2017, 130: 89. DOI: 10.1182/blood.v130.suppl_1.89.89.Peer-Reviewed Original ResearchPost-operative bleeding eventsPost-operative bleedingEntity's Board of DirectorsOpen-label phase 3 studyTooth extractionBleeding eventsHAVEN 1Surgical proceduresCSL BehringTreated with BPAInterim analysisHAVEN 2Hemophilia AFrequency of post-operative bleedingSurgical experienceClinical studiesHemophilia A with inhibitorsKnee arthroscopyInvestigational clinical studyPfizer Inc.Treated with emicizumabPre-operative treatmentPhase 3 studyPrevention of bleedingAnalysis of patients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply